Advertisement

Pharmacy

Bloomfield, Conn.-based Cigna dropped coverage for Mylan's EpiPen and EpiPen Jr. auto-injectors in favor of its generic alternative according to the payer's prescription drug list changes, which were effective Jan. 7. 

Health insurer Blue Cross Blue Shield of Nebraska will cover minimally invasive sacroiliac joint fusion using San Jose, Calif.-based SI Bone's device indicated for fusion for certain disorders of the joint.

Advertisement

Minnetonka, Minn.-based UnitedHealth Group made a deal with Kalamazoo, Mich.-based medical technology producer Medtronic in May, which effectively decreased the number of in-network portable insulin pumps it offers members from nine to three, The New York Times reported.

Woonsocket, R.I.-based CVS Health outlined five strategies the company deployed in its retail pharmacy services for a consumer-driven approach to healthcare, according to DrugStoreNews.

 The market for laparoscopy devices, as reported by Transparency Market Research, is projected to reach $13,152.9 million in 2018, a substantial increase from its worth of $6,968 million in 2011.

Pacira Pharmaceuticals headquartered in Parsippany, N.J., reported the success of its EXPAREL, in the United States with net product sales totaling at $44.9 million in the second quarter of 2014 compared with $15.2 million in the second quarter of 2013.

Advertisement